DS
SLS icon

David Shaw’s SELLAS Life Sciences SLS Stock Holding History

David Shaw’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,086
Closed -$148K – 5743
2022
Q1 		$148K Buy
22,086
+2,943
+15% +$17.2K ﹤0.01% 4939
2021
Q4 		$106K Sell
19,143
-10,778
-36% -$81.5K ﹤0.01% 5052
2021
Q3 		$274K Sell
29,921
-2,193
-7% -$20.3K ﹤0.01% 4410
2021
Q2 		$356K Buy
+32,114
New +$313K ﹤0.01% 4194
2017
Q4 		– Sell
-12
Closed -$6K – 3725
2017
Q3 		$6K Sell
12
-4
-25% -$2.64K ﹤0.01% 3422
2017
Q2 		$14K Buy
+16
New +$13.9K ﹤0.01% 3328
2017
Q1 		– Sell
-123
Closed -$358K – 3574
2016
Q4 		$358K Buy
+123
New +$715K ﹤0.01% 3038

Other funds holding SLS

EAM
Empery Asset Management New York $86.5M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

David Shaw's SLS Position: Q2 2022 in Review

David Shaw sold out of SELLAS Life Sciences (SLS) in Q2 2022, closing a stake of 22,086 shares — an estimated $148K sold.

David Shaw first reported a position in SLS in Q4 2016 and held it in 7 quarters. The position peaked at $358K in Q4 2016. 26 funds tracked by Wall St. Rank hold SLS as of Q2 2022.

  • David Shaw reported no remaining SELLAS Life Sciences position as of Q2 2022 after selling out during the quarter.
  • David Shaw sold 22,086 SELLAS Life Sciences shares in Q2 2022, an estimated $148K.
  • David Shaw first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 7 quarters.
  • David Shaw's SELLAS Life Sciences position peaked at $358K in Q4 2016.
  • 26 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.